Talphera, Inc. (TLPH)
NASDAQ: TLPH · Real-Time Price · USD
0.5250
+0.0134 (2.62%)
May 2, 2025, 4:00 PM EDT - Market closed
Talphera Market Cap
Talphera has a market cap or net worth of $9.15 million as of May 2, 2025. Its market cap has decreased by -46.52% in one year.
Market Cap
9.15M
Enterprise Value
6.81M
1-Year Change
-46.52%
Ranking
Category
Stock Price
$0.53
Market Cap Chart
Since February 14, 2011, Talphera's market cap has decreased from $84.80M to $9.15M, a decrease of -89.21%. That is a compound annual growth rate of -14.49%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 2, 2025 | 9.10M | 2.25% |
Dec 31, 2024 | 8.90M | -28.80% |
Dec 29, 2023 | 12.50M | -25.60% |
Dec 30, 2022 | 16.80M | -74.85% |
Dec 31, 2021 | 66.80M | -40.46% |
Dec 31, 2020 | 112.20M | -33.17% |
Dec 31, 2019 | 167.90M | 17.41% |
Dec 31, 2018 | 143.00M | 40.33% |
Dec 29, 2017 | 101.90M | -13.57% |
Dec 30, 2016 | 117.90M | -31.09% |
Dec 31, 2015 | 171.10M | -41.84% |
Dec 31, 2014 | 294.20M | -39.56% |
Dec 31, 2013 | 486.80M | 404.46% |
Dec 31, 2012 | 96.50M | 157.33% |
Dec 30, 2011 | 37.50M | -55.78% |
View and export this data all the way back to 2011.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 713.09B |
Johnson & Johnson | 371.64B |
UnitedHealth Group | 364.71B |
AbbVie | 342.01B |
Novo Nordisk | 298.09B |
Abbott Laboratories | 227.71B |
Novartis AG | 223.05B |
AstraZeneca | 218.59B |